NCT03558828

Brief Summary

This study employs a Sequential Multiple Assignment Randomized Trial (SMART) and aims to determine the most effective adaptive intervention combining four efficacious treatments (enhanced physical activity monitor, motivational text messages, motivational personal calls, group meetings) to increase physical activity and improve cardiovascular health among sedentary employed women.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
301

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 23, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 15, 2018

Completed
2 months until next milestone

Study Start

First participant enrolled

August 24, 2018

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 28, 2023

Completed
1.8 years until next milestone

Results Posted

Study results publicly available

May 30, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
Last Updated

August 3, 2025

Status Verified

July 1, 2025

Enrollment Period

5 years

First QC Date

April 23, 2018

Results QC Date

December 19, 2024

Last Update Submit

July 23, 2025

Conditions

Keywords

physical activitywomensedentaryaccelerometertext messagegroup meetingpersonal callworkplacecost-effectivenessSequential Multiple Assignment Randomized Trialadaptive interventionActigraphFitbitiCardia

Outcome Measures

Primary Outcomes (2)

  • Physical Activity-Steps

    Physical activity-Steps: Average daily steps were measured with ActiGraph worn on the right hip during waking hours for one week.

    Baseline plus change is being assessed after 8 weeks, 34 weeks, and 50 weeks for steps.

  • Physical Activity- Moderate to Vigorous Physical Activity (MVPA)

    Average daily minutes of Moderate to Vigorous Physical Activity (MVPA) were measured with ActiGraph worn on the right hip during waking hours for one week.

    Baseline plus change is being assessed after 8 weeks, 34 weeks, and 50 weeks for MVPA.

Secondary Outcomes (3)

  • Cardiovascular Health (1)

    Baseline plus change is being assessed after 8 weeks, 34 weeks, and 50 weeks for aerobic fitness.

  • Cardiovascular Health (2)

    Baseline plus change is being assessed after 8 weeks, 34 weeks, and 50 weeks for BMI.

  • Cardiovascular Health (3)

    Baseline plus change is being assessed after 8 weeks, 34 weeks, and 50 weeks for waist measurement.

Study Arms (3)

Step1: Initial Treatment

EXPERIMENTAL

Participants will be randomly assigned to one of the two initial treatment components: a) enhanced physical activity monitor only (physical activity monitor with goal setting and a physical activity prescription) treatment, or b) enhanced physical activity monitor+ motivational text messaging treatment for 8 weeks (early adoption phase). All participants will be given a physical activity step goal The initial treatment time period is from Weeks 1-8.

Behavioral: Step 1: PA MonitorBehavioral: Step 1: PA Monitor + Text

Step 2: Augmented Treatment

EXPERIMENTAL

At Week 8, it will be determined if a women has met her physical activity step goal. If she has, then she will be classified as a responder, and will continue with the same initial treatment component for weeks 9-34 (later adoption). If a woman has not met her physical activity step goal she will be classified as a non-responder. In addition to the initial treatment component non-responders to initial treatments will be randomly assigned to one of two augmented treatment components: a) personal calls, or b) group meetings for Weeks 9-34 (later adoption phase).

Behavioral: Step 2: PA Monitor with CallsBehavioral: Step 2: PA Monitor with MeetingsBehavioral: Step 2: PA Monitor + Texts with CallsBehavioral: Step 2: PA Monitor + Texts with Meetings

Step 3: Maintenance

EXPERIMENTAL

At Weeks 35-50 (maintenance phase) all participants in the study return to an enhanced physical activity monitor only treatment component.

Behavioral: Step 3: PA Monitor

Interventions

The participant will receive an enhanced physical activity monitor treatment for weeks 1-8, which includes goal setting with a physical activity prescription, and self-monitoring with a physical activity monitor.

Step1: Initial Treatment

The participant will receive an enhanced physical activity monitor treatment for weeks 1-8, which includes goal setting with a physical activity prescription, and self-monitoring with a physical activity monitor. In addition, these participants will receive motivational text messages. For participants who remain less than halfway to their daily step goal by a designated daily time, a motivational text message with a strategy to overcome barriers will be sent.

Step1: Initial Treatment

Nonresponders to the enhanced physical activity monitor, will receive an augmented treatment. The participant will continue to receive an enhanced physical activity monitor treatment for weeks 9-34. In addition they will receive ten brief motivational telephone calls, made by an interventionist, every two to three weeks during weeks 9-34.

Step 2: Augmented Treatment

Nonresponders to the enhanced physical activity monitor, will receive an augmented treatment. The participant will continue to receive an enhanced physical activity monitor treatment for weeks 9-34. In addition, the participant will take part in five 45-minute group meetings held every four to six weeks during Weeks 9-34.

Step 2: Augmented Treatment

Nonresponders to the enhanced physical activity monitor plus text messaging, will receive an augmented treatment. The participant will continue to receive an enhanced physical activity monitor treatment for weeks 9-34. In addition, these participants will continue to receive motivational text messages. For participants who remain less than halfway to their daily step goal by a designated daily time, a motivational text message with a strategy to overcome barriers will be sent. In addition they will receive ten brief motivational telephone calls, made by an interventionist, every two to three weeks during weeks 9-34.

Step 2: Augmented Treatment

Nonresponders to the enhanced physical activity monitor plus text messaging, will receive an augmented treatment. The participant will continue to receive an enhanced physical activity monitor treatment for weeks 9-34. In addition, these participants will continue to receive motivational text messages. For participants who remain less than halfway to their daily step goal by a designated daily time, a motivational text message with a strategy to overcome barriers will be sent. In addition, the participant will take part in five 45-minute group meetings held every four to six weeks during Weeks 9-34.

Step 2: Augmented Treatment

During Weeks 35-50, all women will receive enhanced physical activity monitors only.

Step 3: Maintenance

Eligibility Criteria

Age18 Years - 70 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female employee at study site
  • Aged 18 to 70
  • Able to speak/read English
  • Owns a smartphone with text messaging capability
  • Willing to receive text messages at the proposed pace
  • We will include participants who have Type 1 diabetes, or Type 2 diabetes with an A1C ≥ 9.0%, or have an A1C of ≥ 6.5% without a prior diabetes diagnosis, only if they have been given clearance by their health care provider
  • Without a disability that inhibits walking as determined by the PAR-Q \& You (Physical Activity Readiness Questionnaire)

You may not qualify if:

  • Major signs/symptoms of pulmonary or cardiovascular disease
  • Systolic BP ≥ 160 and/or diastolic BP ≥ 100
  • Sufficiently or overly active, as determined by a physical activity monitor worn for one week, indicating averaging ≥ 7,500 steps per day ("somewhat active")

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rush University College of Nursing

Chicago, Illinois, 60612, United States

Location

Related Publications (5)

  • Buchholz SW, Ingram D, Wilbur J, Fogg L, Sandi G, Moss A, Ocampo EV. Bilingual Text4Walking Food Service Employee Intervention Pilot Study. JMIR Mhealth Uhealth. 2016 Jun 1;4(2):e68. doi: 10.2196/mhealth.5328.

    PMID: 27251878BACKGROUND
  • Wilbur J, Miller AM, Fogg L, McDevitt J, Castro CM, Schoeny ME, Buchholz SW, Braun LT, Ingram DM, Volgman AS, Dancy BL. Randomized Clinical Trial of the Women's Lifestyle Physical Activity Program for African-American Women: 24- and 48-Week Outcomes. Am J Health Promot. 2016 May;30(5):335-45. doi: 10.1177/0890117116646342.

    PMID: 27404642BACKGROUND
  • Buchholz SW, Wilbur J, Halloway S, Schoeny M, Johnson T, Vispute S, Kitsiou S. Study protocol for a sequential multiple assignment randomized trial (SMART) to improve physical activity in employed women. Contemp Clin Trials. 2020 Feb;89:105921. doi: 10.1016/j.cct.2019.105921. Epub 2019 Dec 30.

    PMID: 31899371BACKGROUND
  • Daniel M, Buchholz SW, Schoeny M, Halloway S, Kitsiou S, Johnson T, Vispute S, Kapp M, Wilbur J. Effects of the COVID-19 pandemic on recruitment for the working women walking program. Res Nurs Health. 2022 Oct;45(5):559-568. doi: 10.1002/nur.22258. Epub 2022 Sep 12.

    PMID: 36093873BACKGROUND
  • Buchholz SW, Daniel M, Kitsiou S, Schoeny ME, Halloway S, Johnson TJ, Vispute S, Wilbur J. Working Women Walking Program: A Sequential Multiple Assignment Randomized Trial. J Phys Act Health. 2025 May 6;22(7):778-792. doi: 10.1123/jpah.2024-0790. Print 2025 Jul 1.

    PMID: 40328439BACKGROUND

MeSH Terms

Conditions

Motor ActivitySedentary Behavior

Condition Hierarchy (Ancestors)

Behavior

Results Point of Contact

Title
Manju Daniel
Organization
Rush University College of Nursing

Study Officials

  • Susan Buchholz, PhD

    Michigan State University, College of Nursing

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
SEQUENTIAL
Model Details: A Sequential Multiple Assignment Randomized Trial (SMART) design is used for this study.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 23, 2018

First Posted

June 15, 2018

Study Start

August 24, 2018

Primary Completion

August 28, 2023

Study Completion

June 30, 2025

Last Updated

August 3, 2025

Results First Posted

May 30, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations